1. Home
  2. DNLI vs TRMK Comparison

DNLI vs TRMK Comparison

Compare DNLI & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • TRMK
  • Stock Information
  • Founded
  • DNLI 2013
  • TRMK 1889
  • Country
  • DNLI United States
  • TRMK United States
  • Employees
  • DNLI N/A
  • TRMK N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • TRMK Major Banks
  • Sector
  • DNLI Health Care
  • TRMK Finance
  • Exchange
  • DNLI Nasdaq
  • TRMK Nasdaq
  • Market Cap
  • DNLI 2.1B
  • TRMK 2.2B
  • IPO Year
  • DNLI 2017
  • TRMK 1987
  • Fundamental
  • Price
  • DNLI $13.98
  • TRMK $38.14
  • Analyst Decision
  • DNLI Strong Buy
  • TRMK Buy
  • Analyst Count
  • DNLI 15
  • TRMK 4
  • Target Price
  • DNLI $33.85
  • TRMK $41.00
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • TRMK 355.9K
  • Earning Date
  • DNLI 08-04-2025
  • TRMK 07-22-2025
  • Dividend Yield
  • DNLI N/A
  • TRMK 2.43%
  • EPS Growth
  • DNLI N/A
  • TRMK 17.79
  • EPS
  • DNLI N/A
  • TRMK 3.56
  • Revenue
  • DNLI N/A
  • TRMK $752,248,000.00
  • Revenue This Year
  • DNLI N/A
  • TRMK $57.30
  • Revenue Next Year
  • DNLI $323.34
  • TRMK $3.88
  • P/E Ratio
  • DNLI N/A
  • TRMK $11.10
  • Revenue Growth
  • DNLI N/A
  • TRMK 40.09
  • 52 Week Low
  • DNLI $10.57
  • TRMK $29.77
  • 52 Week High
  • DNLI $33.33
  • TRMK $40.73
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 45.66
  • TRMK 56.88
  • Support Level
  • DNLI $13.70
  • TRMK $37.25
  • Resistance Level
  • DNLI $14.60
  • TRMK $39.66
  • Average True Range (ATR)
  • DNLI 0.65
  • TRMK 0.98
  • MACD
  • DNLI -0.06
  • TRMK -0.11
  • Stochastic Oscillator
  • DNLI 13.13
  • TRMK 46.48

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

Share on Social Networks: